MarketBeat reported average ratings and TD Cowen reaffirmed a buy rating for Ionis Pharmaceuticals.

The entities involved

• Ionis Pharmaceuticals →

  American pharmaceutical company

  • GSK and Ionis Pharmaceuticals co-developed the bepirovirsen drug for hepatitis B.Sat 18:16
• MarketBeat →

  American personal finance blog

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15
• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36

Related events

• Analyst firms Jefferies and TD Cowen upgraded their ratings for Forgent Power Solutions, Inc., while MarketBeat provided consensus data.Sep 15
• MarketBeat published average ratings and price targets for Kalaris Therapeutics, while Citigroup reaffirmed an outperform rating and TD Cowen initiated coverage with a buy rating.Sep 8
• TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.Jul 18
• TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.Aug 27
• TD Cowen upgraded Cabaletta Bio shares to strong-buy, while Jefferies reissued a buy rating, and MarketBeat provided consensus data.Sep 14